RAM
MIRM icon

RWC Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History

RWC Asset Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$216K Sell
2,341
-793
-25% -$74.6K 0.01% 159
2025
Q4 		$248K Sell
3,134
-663
-17% -$47.6K 0.01% 158
2025
Q3 		$278K Buy
+3,797
New +$241K 0.01% 162

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

RWC Asset Management's MIRM Position: Q1 2026 in Review

RWC Asset Management reduced its Mirum Pharmaceuticals (MIRM) stake by 25% in Q1 2026, selling an estimated $74.6K and leaving 2,341 shares worth $216K. The position accounts for 0.01% of the portfolio, ranked #159.

RWC Asset Management first reported a position in MIRM in Q3 2025 and has held it in 3 quarters since. The position peaked at $278K in Q3 2025. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • RWC Asset Management held 2,341 shares of Mirum Pharmaceuticals worth $216K as of Q1 2026.
  • RWC Asset Management sold 793 Mirum Pharmaceuticals shares in Q1 2026, an estimated $74.6K.
  • Mirum Pharmaceuticals made up 0.01% of RWC Asset Management's portfolio in Q1 2026, its #159 holding.
  • RWC Asset Management first reported a position in Mirum Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • RWC Asset Management's Mirum Pharmaceuticals position peaked at $278K in Q3 2025.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on RWC Asset Management's 13F filing for Q1 2026, filed 27 Apr 2026.